GLP-1 Analogues Market Set to Reach USD 211.8 Billion by 2035 as Diabetes and Obesity Burden Accelerates Global Demand
The global GLP-1 analogues market is experiencing unprecedented growth as healthcare systems increasingly adopt advanced therapies for the management of type 2 diabetes, obesity, and cardiometabolic disorders. Valued at US$ 51.6 billion in 2024, the market is projected to expand at a robust CAGR of 13.7% from 2025 to 2035, reaching an estimated US$ 211.8 billion by 2035. The...
0 Comments 0 Shares 4 Views 0 Reviews
Sponsored

Real Profits Start Here – Try Stockity Today!

Experience fast and simple online trading with Stockity. Learn, practice, and trade with real-time market tools designed for everyone — beginners to pros.